Confident in the science, but worried about repercussions At Gwinnett Pediatrics and Adolescent Medicine, pediatrician Keyana Washington says she is sticking by science
Cell Res (2017) 27:74863
CVS Caremark removed Zepbound (tirzepatide) from its Standard, Advanced Control, and Value formulariesthe ones used by most employersand has confirmed "no new GLP-1 formulary changes" for January 2026
It is also indicated for the supportive treatment of neuritis & non-inflammatory diseases of the nerves, e.g.- Vitamin B1 converts carbohydrates, fatty acids, and amino acids into energy, promotes healthy nerves, improves mood, and strengthens the heart
In clinical trials, roughly 13.6% of semaglutide participants didn't achieve 5% weight loss after 68 weeks at the highest dose, while tirzepatide non-response rates were 9-11%